3-hydroxyphencyclidine Usage And Synthesis

Description

3-Hydroxyphencyclidine (3-HO-PCP) is a dissociative hallucinogen of the arylcyclohexylamine class related to phencyclidine (PCP) that has been sold online as a designer drug.
On October 18, 2012 the Advisory Council on the Misuse of Drugs in the United Kingdom released a report about methoxetamine, saying that the "harms of methoxetamine are commensurate with Class B of the Misuse of Drugs Act (1971)", despite the fact that the act does not classify drugs based on harm. The report went on to suggest that all analogues of MXE should also become class B drugs and suggested a catch-all clause covering both existing and unresearched arylcyclohexamines, including 3-HO-PCP.

3-hydroxyphencyclidine(79787-43-2)Related Product Information

• MAF
• 4-Chloro-3-methylphenol
• 4-CPRC
• Trenbolone cyclohexylmethylcarbonate
• 2,3,5,6-TETRAMETHYL-1,4-PHENYLENEDIAMINE